http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020077030-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bc7693dae06e6b3ff39c820ec91bf5db |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-515 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1891 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-475 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 |
filingDate | 2019-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2c4a69824449584cbaa4d00e81e4fd3 |
publicationDate | 2020-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | WO-2020077030-A1 |
titleOfInvention | Aggf1 and aggf1-primed cells for treating diseases and conditions |
abstract | Provided herein are compositions, systems, kits, and methods for treating a subject with a disease or condition characterized by abnormal glucose metabolism (e.g., diabetes) or ischemic vascular disease (e.g., PAD or CAD) by administering a composition comprising AGGF1 peptides, or an expression vector encoding said peptides, or AGGF1-primed endothelial progenitor cells, to a subject. In certain embodiments, the AGGF1 peptide is full-length AGGF1, or a biologically active fragment or mutant thereof. In some embodiments, the AGGF1 peptides or expression vectors are administered around the same time insulin is administered to the subject. |
priorityDate | 2018-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 548.